CASE DISCUSSION

Interpreting Semen Analysis Results: Insights into Male Reproductive Health

Presented from India by Dr. Muhammed Asif

Likes

1687

Views

Bookmarks

Case Description

Semen analysis is a critical tool for evaluating male reproductive health and diagnosing infertility. Key parameters include sperm concentration, motility, morphology, volume, and pH. Normal values, based on WHO guidelines, indicate healthy sperm production and function. Deviations, such as low...

Case Summary

Semen analysis is crucial for assessing male fertility. The process involves taking a patient's history, conducting a physical examination, and performing tests, including hormonal profiles. The physical exam includes checking the penis, scrotum, and testes size.

Speaker Profile

Dr. Muhammed Asif

Senior Embryologist & IVF Lab Manager, Ludhiana, Punjab

Dr. Muhammed Asif is currently working as a Senior Embryologist at Cloudnine Fertility, Punjab, India. He has actively participated in many research projects and has been fortunate enough to contribute to numerous research publications. As a Chief Research Officer/Research Director, he was heading the entire research wing of Garbha Gudi IVF Bengaluru, India. He guided Reproductive Medicine Fellowship (FRM) and Clinical Embryology students for research projects related to Reproductive Medicine. He is Faculty for Fellowship in Reproductive Medicine (FRM) and Clinical Embryology course in GarbhaGudi Institute of Reproductive Health & Research.He is examiner for Reproductive Medicine Fellowship doctors, Clinical Embryology, MBBS, and BDS. He has expertise in Intracytoplasmic Sperm Injection (ICSI), IVF (Invitro fertilization), Well versed in embryo culture systems, Morphological assessment of oocytes and embryos, Blastocyst culture, vitrification and transfer, Cryopreservation of oocyte, Embryo cryopreservation, Frozen embryo transfer (FET), Laser hatched embryo. He has published various papers and invited as guest speaker nationally & Internationally.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.